These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15055524)

  • 1. The correlation between cyclooxygenase-2 expression and hepatocellular carcinogenesis.
    Sung YK; Hwang SY; Kim JO; Bae HI; Kim JC; Kim MK
    Mol Cells; 2004 Feb; 17(1):35-8. PubMed ID: 15055524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation.
    Koga H; Sakisaka S; Ohishi M; Kawaguchi T; Taniguchi E; Sasatomi K; Harada M; Kusaba T; Tanaka M; Kimura R; Nakashima Y; Nakashima O; Kojiro M; Kurohiji T; Sata M
    Hepatology; 1999 Mar; 29(3):688-96. PubMed ID: 10051469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
    Bae SH; Jung ES; Park YM; Kim BS; Kim BK; Kim DG; Ryu WS
    Clin Cancer Res; 2001 May; 7(5):1410-8. PubMed ID: 11350912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma.
    Kondo M; Yamamoto H; Nagano H; Okami J; Ito Y; Shimizu J; Eguchi H; Miyamoto A; Dono K; Umeshita K; Matsuura N; Wakasa K; Nakamori S; Sakon M; Monden M
    Clin Cancer Res; 1999 Dec; 5(12):4005-12. PubMed ID: 10632332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma.
    Cheng AS; Chan HL; To KF; Leung WK; Chan KK; Liew CT; Sung JJ
    Int J Oncol; 2004 Apr; 24(4):853-60. PubMed ID: 15010822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 expression in hepatocellular carcinoma.
    Shiota G; Okubo M; Noumi T; Noguchi N; Oyama K; Takano Y; Yashima K; Kishimoto Y; Kawasaki H
    Hepatogastroenterology; 1999; 46(25):407-12. PubMed ID: 10228831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma.
    Gao YW; Chen YX; Wang ZM; Zhou LD; Li XY; Li LX; Luo QZ; Tian W; Fu CY; Zhou JH
    Hepatogastroenterology; 2008; 55(82-83):345-50. PubMed ID: 18613363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells.
    Lampiasi N; Foderà D; D'Alessandro N; Cusimano A; Azzolina A; Tripodo C; Florena AM; Minervini MI; Notarbartolo M; Montalto G; Cervello M
    Int J Mol Med; 2006 Feb; 17(2):245-52. PubMed ID: 16391822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of stomach cancer-associated protein tyrosine phosphatase-1 (SAP-1) in advanced human hepatocellular carcinoma.
    Nagano H; Noguchi T; Inagaki K; Yoon S; Matozaki T; Itoh H; Kasuga M; Hayashi Y
    Oncogene; 2003 Jul; 22(30):4656-63. PubMed ID: 12879010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Id proteins in human hepatocellular carcinoma: relevance to tumor dedifferentiation.
    Damdinsuren B; Nagano H; Kondo M; Yamamoto H; Hiraoka N; Yamamoto T; Marubashi S; Miyamoto A; Umeshita K; Dono K; Nakamori S; Wakasa K; Sakon M; Monden M
    Int J Oncol; 2005 Feb; 26(2):319-27. PubMed ID: 15645115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of c-Yes expression in the nuclei of hepatocellular carcinoma cells: involvement in the early stages of hepatocarcinogenesis.
    Nonomura T; Masaki T; Morishita A; Jian G; Uchida N; Himoto T; Izuishi K; Iwama H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
    Int J Oncol; 2007 Jan; 30(1):105-11. PubMed ID: 17143518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of cyclooxygenase-2 in carcinoma of the pancreas.
    Okami J; Yamamoto H; Fujiwara Y; Tsujie M; Kondo M; Noura S; Oshima S; Nagano H; Dono K; Umeshita K; Ishikawa O; Sakon M; Matsuura N; Nakamori S; Monden M
    Clin Cancer Res; 1999 Aug; 5(8):2018-24. PubMed ID: 10473081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential cyclooxygenase-2 enzyme expression in radiosensitive versus radioresistant glioblastoma multiforme cell lines.
    Karim A; McCarthy K; Jawahar A; Smith D; Willis B; Nanda A
    Anticancer Res; 2005; 25(1B):675-9. PubMed ID: 15816645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of dihydrodiol dehydrogenase expression in resected hepatocellular carcinoma.
    Yang MD; Wu CC; Chiou SH; Chiu CF; Lin TY; Chiang IP; Chow KC
    Oncol Rep; 2003; 10(2):271-6. PubMed ID: 12579257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human esophageal mucosa, dysplasia and carcinoma.
    Kase S; Osaki M; Honjo S; Hashimoto K; Adachi H; Tsujitani S; Ito H
    Pathobiology; 2004; 71(2):84-92. PubMed ID: 14707443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases.
    Rahman MA; Dhar DK; Yamaguchi E; Maruyama S; Sato T; Hayashi H; Ono T; Yamanoi A; Kohno H; Nagasue N
    Clin Cancer Res; 2001 May; 7(5):1325-32. PubMed ID: 11350902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cyclooxygenase-2 in malignant and benign breast tumors.
    Watanabe O; Shimizu T; Imamura H; Kinoshita J; Utada Y; Okabe T; Kimura K; Hirano A; Yoshimatsu K; Aiba M; Ogawa K
    Anticancer Res; 2003; 23(4):3215-21. PubMed ID: 12926055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
    Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
    Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of cyclooxygenase-2 in esophageal squamous cell carcinogenesis].
    Yu HP; Liu L; Shi LY; Lu WH; Xu SQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Jan; 38(1):22-5. PubMed ID: 14989896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinoma.
    Masaki T; Tokuda M; Ohnishi M; Watanabe S; Fujimura T; Miyamoto K; Itano T; Matsui H; Arima K; Shirai M; Maeba T; Sogawa K; Konishi R; Taniguchi K; Hatanaka Y; Hatase O; Nishioka M
    Hepatology; 1996 Jul; 24(1):72-81. PubMed ID: 8707286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.